The Role of CYP8B1 Polymorphisms in Modulating the Biochemical Pathways Affected by SGLT2 Inhibitors in T2DM and Obesity
NCT07120828 · COMPLETED · Phase 4
We track 1 ClinicalTrials.gov studies led by Erbil Polytechnic University. The portfolio skews toward Phase 4 (1 trials).
1 clinical trials sponsored by Erbil Polytechnic University.
| Phase | Trials | Distribution |
|---|---|---|
| Phase 4 | 1 | 100% |
Erbil Polytechnic University currently sponsors 1 clinical trials tracked on ReadTheTrial. These span Phase 4.
Erbil Polytechnic University conducts research across multiple therapeutic areas. Browse the trial listings for details.
Check the trial listings below for current recruitment status. Trial recruitment status can change frequently.